Dr. Keller is an Adjunct Assistant Professor in the Department of Health Policy and Management. Her primary appointment is in the Division of General Internal Medicine, Department of Medicine at Cedars-Sinai Medical Center. Dr. Keller's research focuses on the use, prescribing, and deprescribing of high-risk medications such as opioids, benzodiazepines, and antipsychotics in older adults. Dr. Keller's current projects are focused on testing the effectiveness of a population health approach to deprescribing and optimizing medications in older adults with polypharmacy (NIA K01), using implementation strategies to increase benzodiazepine deprescribing in a large health system, and developing interventions to increase the deprescribing of benzodiazepines in the inpatient setting. Dr. Keller’s research has been published in peer-reviewed publications including JAMA Surgery, Health Services Research, the Journal of Hospital Medicine, Pain Medicine, npj Digital Medicine, Psychiatric Services, and the American Journal of Managed Care. Prior to working in health care, Dr. Keller worked as a journalist for publications such as the Los Angeles Times and the Chicago Tribune.
Michelle S. Keller
- PhD, Health Policy and Management, University of California, Los Angeles, CA
- MPH, Health Policy and Management, University of California, Los Angeles, CA
- BA, Human Biology, Stanford University, Stanford, CA
Areas of Interest
Dr. Keller studies the prescribing and use of high-risk medications in older adults, including opioids, benzodiazepines, and antipsychotics. Dr. Keller also examines ways to improve patient-clinician communication.